tradingkey.logo
tradingkey.logo
Pesquisar

Sanara Medtech Inc

SMTI
Adicionar à lista de desejos
24.840USD
+0.570+2.35%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
227.66MValor de mercado
PerdaP/L TTM

Mais detalhes de Sanara Medtech Inc Empresa

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Informações de Sanara Medtech Inc

Código da empresaSMTI
Nome da EmpresaSanara Medtech Inc
Data de listagemApr 07, 1994
CEOMuppalla (Suresh V)
Número de funcionários141
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 07
Endereço1200 Summit Avenue
CidadeFORT WORTH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal76102
Telefone18175292300
Sitehttps://sanaramedtech.com/
Código da empresaSMTI
Data de listagemApr 07, 1994
CEOMuppalla (Suresh V)

Executivos da empresa Sanara Medtech Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
9.32K
+47.02%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Robert A. (Bob) DeSutter
Mr. Robert A. (Bob) DeSutter
Independent Director
Independent Director
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%

Perguntas frequentes

Quem são os cinco principais acionistas de Sanara Medtech Inc?

Os cinco principais acionistas de Sanara Medtech Inc são: Mr. Seth D. Yon

Quantas instituições possuem ações da Sanara Medtech Inc (SMTI)?

Em 2026Q1, 131 instituições possuíam ações da Sanara Medtech Inc, com valor de mercado aproximado de 1.42M, representando 15.50% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -599767.00.

Qual é a maior fonte de receita da Sanara Medtech Inc?

Em 2026Q1, o segmento de negócios Soft tissue repair products gerou a maior receita para Sanara Medtech Inc, totalizando 91.35M e representando 88.59% da receita total.